These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14172076)

  • 1. VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA.
    BURDICK KH; HAWK WA
    Cancer; 1964 Jun; 17():708-12. PubMed ID: 14172076
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of vaccinia virus in the treatment of metastatic malignant melanoma.
    Hunter-Craig I; Newton KA; Westbury G; Lacey BW
    Br Med J; 1970 May; 2(5708):512-5. PubMed ID: 4913781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALIGNANT MELANOMAS IN SMALLPOX VACCINATION SCARS. REPORT OF SIX CASES.
    MARMELZAT WL; MARTEL S
    Arch Dermatol; 1964 Jun; 89():823-6. PubMed ID: 14164967
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy of malignant melanoma with vaccinia virus.
    Roenigk HH; Deodhar S; St Jacques R; Burdick K
    Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.
    Rosenberg SA; White DE
    J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):81-4. PubMed ID: 8859727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete regression of melanoma associated with vitiligo.
    Piqué-Duran E; Palacios-Llopis S; Martínez-Martín M; Pérez-Cejudo JA
    Dermatol Online J; 2011 Jan; 17(1):4. PubMed ID: 21272495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of melanoma metastases with smallpox vaccine and Freund's adjuvant].
    Herrmann WP; Tritsch H
    Munch Med Wochenschr; 1970 Oct; 112(42):1916. PubMed ID: 5536277
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccinia virus: the possibilities of its oncogenicity in humans.
    Michel N; Aguilera A; Miller A; Miller AO
    Cancer Lett; 1976 Mar; 1(4):225-30. PubMed ID: 1016948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FATAL HOMOTRANSPLANTED MELANOMA: A CASE REPORT.
    SCANLON EF; HAWKINS RA; FOX WW; SMITH WS
    Cancer; 1965 Jun; 18():782-9. PubMed ID: 14297475
    [No Abstract]   [Full Text] [Related]  

  • 11. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
    Arpaia N; Cassano N; Vena GA
    Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Spontaneous regression and leukoderma in malignant melanoma].
    Happle R; Schotola I; Macher E
    Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of the effects of inoculated and intralymphatic vaccinia virus on primary and secondary deposits of malignant melanoma.
    Dent RI; Cruickshank JG; Gordon JA; Swanepoel R
    Cent Afr J Med; 1972 Sep; 18(9):173-6. PubMed ID: 4650359
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regression of melanoma metastases after immunological therapy].
    Malek-Mansour S; Castermans-Elias S; Lapière CM
    Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
    [No Abstract]   [Full Text] [Related]  

  • 15. Viruses and cancer.
    Nelson NJ
    J Natl Cancer Inst; 1999 Oct; 91(20):1709. PubMed ID: 10528014
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
    Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
    J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CONSIDERATIONS ON THE CURE OF PIGMENTED NEVI OF MALIGNANT MELANOMAS AND THE PRECANCEROUS MELANOSIS OF DUBHREUIHL].
    MORONI P
    Arch Ital Dermatol Venereol Sessuol; 1963 Oct; 32():124-41. PubMed ID: 14104037
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis.
    Teulings HE; Limpens J; Jansen SN; Zwinderman AH; Reitsma JB; Spuls PI; Luiten RM
    J Clin Oncol; 2015 Mar; 33(7):773-81. PubMed ID: 25605840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of malignant melanoma.
    Manelis G; Shasha SM; Manelis J; Suprun H; Robinson E
    Oncology; 1978; 35(2):83-6. PubMed ID: 652267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ON THE NATURE OF KERATOACANTHOMA AND ITS POSITION AMONG EPITHELIO-CUTANEOUS TUMORS. (A CASE OF MALIGNANT KERATOACANTHOMA)].
    NICOLAU SG; BALUS L
    Oncologia; 1964; 17():120-34. PubMed ID: 14115964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.